BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7693530)

  • 41. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 42. Adsorption of alpha-amylase (EC 3.2.1.1) and lipase (EC 3.1.1.3) before and after substitution therapy in exocrine pancreatic insufficiency.
    Gregar I; Kojecký Z; Matlocha Z
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():233-43. PubMed ID: 2977896
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Substitution of digestive enzymes in elderly patients].
    Jansen W
    Med Welt; 1982 Sep; 33(37):1281-2. PubMed ID: 6182442
    [No Abstract]   [Full Text] [Related]  

  • 45. [Different behavior of lipase, amylase and pancreatic proteolytic enzymes after different means of excitation of the human pancreas].
    Sarles H; Figarella C; Prezelin G; Souville C
    Bull Soc Chim Biol (Paris); 1966; 48(8):951-7. PubMed ID: 5924594
    [No Abstract]   [Full Text] [Related]  

  • 46. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations.
    Delchier JC; Vidon N; Saint-Marc Girardin MF; Soule JC; Moulin C; Huchet B; Zylberberg P
    Aliment Pharmacol Ther; 1991 Aug; 5(4):365-78. PubMed ID: 1777547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro study of a new pancreatic enzyme with high lipase content in enteric coated microtablets].
    Vantini I; Fioretta A; Bonfante F; Brentegnani MT; Benini L; Castellani G
    Clin Ter; 1993 May; 142(5):445-51. PubMed ID: 8339528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring changes in plasma levels of pancreatic and intestinal enzymes in a model of pancreatic exocrine insufficiency--induced by pancreatic duct-ligation--in young pigs.
    Lozinska L; Prykhodko O; Sureda EA; Szwiec K; Podgurniak P; Pierzynowski S; Weström B
    Adv Med Sci; 2015 Mar; 60(1):112-7. PubMed ID: 25658045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activities of gastric, pancreatic, and intestinal brush-border membrane enzymes during postnatal development of dogs.
    Buddington RK; Elnif J; Malo C; Donahoo JB
    Am J Vet Res; 2003 May; 64(5):627-34. PubMed ID: 12755304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of pancreatic exocrine deficiency.
    Sarner M
    World J Surg; 2003 Nov; 27(11):1192-5. PubMed ID: 14534818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of the activities of pancreatic and caecal enzymes in White Roman goslings.
    Shih BL; Hsu JC
    Br Poult Sci; 2006 Feb; 47(1):95-102. PubMed ID: 16546803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of all the lipolytic activities in pancreatin and comparison with porcine and human pancreatic juices.
    Salhi A; Amara S; Mansuelle P; Puppo R; Lebrun R; Gontero B; Aloulou A; Carrière F
    Biochimie; 2020 Feb; 169():106-120. PubMed ID: 31288050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency-dependent secretion of pancreatic amylase, lipase, trypsin, and chymotrypsin during vagal stimulation in rats.
    Rösch T; Schusdziarra V; Olbrich H; Classen M
    Pancreas; 1990 Sep; 5(5):499-506. PubMed ID: 1700413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC
    Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
    [No Abstract]   [Full Text] [Related]  

  • 57. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
    Alkaade S; Vareedayah AA
    Am J Manag Care; 2017 Jul; 23(12 Suppl):S203-S209. PubMed ID: 28727474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic enzyme therapy.
    Mössner J; Keim V
    Dtsch Arztebl Int; 2010 Aug; 108(34-35):578-82. PubMed ID: 21904592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzyme substitution in pancreatic disease.
    Andrén-Sandberg A
    Digestion; 1987; 37 Suppl 1():35-46. PubMed ID: 3650182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.